KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 145 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 1.04 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $8,605,000 | -45.3% | 114,773 | -45.1% | 0.00% | -40.0% |
Q2 2015 | $15,738,000 | +414.7% | 208,968 | +242.6% | 0.01% | – |
Q1 2015 | $3,058,000 | +467.3% | 60,995 | +292.7% | 0.00% | – |
Q4 2014 | $539,000 | -50.6% | 15,534 | -53.3% | 0.00% | – |
Q3 2014 | $1,090,000 | +121.1% | 33,286 | +158.9% | 0.00% | – |
Q2 2014 | $493,000 | +40.5% | 12,858 | +45.7% | 0.00% | – |
Q1 2014 | $351,000 | – | 8,827 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 34,925 | $1,596,000 | 1.83% |
Redmile Group, LLC | 228,218 | $10,430,000 | 1.57% |
Palo Alto Investors LP | 319,113 | $14,548,000 | 1.52% |
Aureus Asset Management, LLC | 92,350 | $4,210,000 | 1.44% |
PFM Health Sciences, LP | 767,892 | $35,007,000 | 0.84% |
EAM Investors, LLC | 60,219 | $2,752,000 | 0.55% |
INVESTOR AB | 80,000 | $3,540,000 | 0.41% |
Partner Investment Management, L.P. | 23,595 | $1,076,000 | 0.29% |
Polar Capital LLP | 230,000 | $10,511,000 | 0.28% |
Old West Investment Management, LLC | 11,130 | $507,000 | 0.24% |